378 related articles for article (PubMed ID: 9820521)
1. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
[TBL] [Abstract][Full Text] [Related]
2. Single amino acid replacements in an antigenic peptide are sufficient to alter the TCR V beta repertoire of the responding CD8+ cytotoxic lymphocyte population.
Kalergis AM; Ono T; Wang F; DiLorenzo TP; Honda S; Nathenson SG
J Immunol; 1999 Jun; 162(12):7263-70. PubMed ID: 10358174
[TBL] [Abstract][Full Text] [Related]
3. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
Messaoudi I; LeMaoult J; Nikolić-Zugić J
J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
[TBL] [Abstract][Full Text] [Related]
4. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
[TBL] [Abstract][Full Text] [Related]
5. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
Dillon SR; Jameson SC; Fink PJ
J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
[TBL] [Abstract][Full Text] [Related]
7. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
Vasmatzis G; Cornette J; Sezerman U; DeLisi C
J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
[TBL] [Abstract][Full Text] [Related]
8. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
9. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
Bristol JA; Schlom J; Abrams SI
J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
[TBL] [Abstract][Full Text] [Related]
10. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner.
Saito NG; Chang HC; Paterson Y
J Immunol; 1999 May; 162(10):5998-6008. PubMed ID: 10229839
[TBL] [Abstract][Full Text] [Related]
11. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR
Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346
[TBL] [Abstract][Full Text] [Related]
12. Carrier-reactive hapten-specific cytotoxic T lymphocyte clones originate from a highly preselected T cell repertoire: implications for chemical-induced self-reactivity.
Martin S; Ruh H; Hebbelmann S; Pflugfelder U; Rüde B; Weltzien HU
Eur J Immunol; 1995 Oct; 25(10):2788-96. PubMed ID: 7589073
[TBL] [Abstract][Full Text] [Related]
13. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys.
Chen ZW; Shen L; Regan JD; Kou Z; Ghim SH; Letvin NL
J Immunol; 1996 Feb; 156(4):1469-75. PubMed ID: 8568249
[TBL] [Abstract][Full Text] [Related]
14. Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I.
Zhang W; Honda S; Wang F; DiLorenzo TP; Kalergis AM; Ostrov DA; Nathenson SG
J Immunol; 2001 Oct; 167(8):4396-404. PubMed ID: 11591764
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
[TBL] [Abstract][Full Text] [Related]
16. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
[TBL] [Abstract][Full Text] [Related]
17. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
[TBL] [Abstract][Full Text] [Related]
18. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
[TBL] [Abstract][Full Text] [Related]
19. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells.
Weltzien HU; Kempkes B; Studer R; Melchers I; Eichmann K
Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649
[TBL] [Abstract][Full Text] [Related]
20. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
